Gadolinium containing contrast agents - Important Safety Information from the Irish Medicines Board
01 February 2011
Important safety information communication from the Irish Medicines Board on the risk of Nephrogenic Systemic Fibrosis (NSF) with gadolinium-containing contrast agents (GdCAs).
Important Safety Information - Gadolinium containing contrast agents